Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MZF1
|
ENSG00000099326.4 | myeloid zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MZF1 | hg19_v2_chr19_-_59084922_59084947 | 0.56 | 3.4e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_72441315 | 6.45 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
chr13_-_72440901 | 5.82 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
chr14_+_24867992 | 5.07 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr15_-_71055769 | 3.25 |
ENST00000539319.1
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chrX_-_70474499 | 3.03 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
chr4_+_41361616 | 3.01 |
ENST00000513024.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
chr3_+_8543393 | 2.43 |
ENST00000157600.3
ENST00000415597.1 ENST00000535732.1 |
LMCD1
|
LIM and cysteine-rich domains 1 |
chr20_+_34742650 | 2.29 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr17_-_47841485 | 2.13 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chrX_-_70474910 | 2.13 |
ENST00000373988.1
ENST00000373998.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr17_+_40913264 | 2.08 |
ENST00000587142.1
ENST00000588576.1 |
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr8_-_81083341 | 2.00 |
ENST00000519303.2
|
TPD52
|
tumor protein D52 |
chr3_+_8543561 | 1.99 |
ENST00000397386.3
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr17_+_42634844 | 1.99 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
chr17_+_40913210 | 1.86 |
ENST00000253796.5
|
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr14_-_23285069 | 1.85 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr6_-_32191834 | 1.84 |
ENST00000375023.3
|
NOTCH4
|
notch 4 |
chr4_+_126237554 | 1.81 |
ENST00000394329.3
|
FAT4
|
FAT atypical cadherin 4 |
chr21_+_17961006 | 1.76 |
ENST00000602323.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr20_+_42574317 | 1.74 |
ENST00000358131.5
|
TOX2
|
TOX high mobility group box family member 2 |
chr4_+_30721968 | 1.73 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr1_+_66999799 | 1.73 |
ENST00000371035.3
ENST00000371036.3 ENST00000371037.4 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
chr11_-_119234876 | 1.70 |
ENST00000525735.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr1_+_66999268 | 1.70 |
ENST00000371039.1
ENST00000424320.1 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
chr11_-_2160180 | 1.68 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr3_+_110790590 | 1.68 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
chr14_-_23285011 | 1.68 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr19_-_38916802 | 1.66 |
ENST00000587738.1
|
RASGRP4
|
RAS guanyl releasing protein 4 |
chr5_-_81046841 | 1.62 |
ENST00000509013.2
ENST00000505980.1 ENST00000509053.1 |
SSBP2
|
single-stranded DNA binding protein 2 |
chrX_-_135849484 | 1.61 |
ENST00000370620.1
ENST00000535227.1 |
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr12_+_53443963 | 1.60 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr1_+_221051699 | 1.54 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chrX_-_119694538 | 1.53 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
chr20_-_45981138 | 1.52 |
ENST00000446994.2
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr15_-_71055878 | 1.51 |
ENST00000322954.6
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr19_-_14201507 | 1.48 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr9_+_2015335 | 1.40 |
ENST00000349721.2
ENST00000357248.2 ENST00000450198.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr20_-_39317868 | 1.39 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr5_-_81046904 | 1.32 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
chr12_+_53443680 | 1.32 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr3_+_8543533 | 1.31 |
ENST00000454244.1
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr18_-_72920372 | 1.28 |
ENST00000581620.1
ENST00000582437.1 |
ZADH2
|
zinc binding alcohol dehydrogenase domain containing 2 |
chr7_+_114562172 | 1.26 |
ENST00000393486.1
ENST00000257724.3 |
MDFIC
|
MyoD family inhibitor domain containing |
chr10_+_119301928 | 1.25 |
ENST00000553456.3
|
EMX2
|
empty spiracles homeobox 2 |
chr14_+_75745477 | 1.22 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr12_+_79258444 | 1.20 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
chrX_-_62974941 | 1.17 |
ENST00000374872.1
ENST00000253401.6 ENST00000374870.4 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
chr19_-_38916839 | 1.16 |
ENST00000433821.2
ENST00000426920.2 ENST00000587753.1 ENST00000454404.2 ENST00000293062.9 |
RASGRP4
|
RAS guanyl releasing protein 4 |
chr18_-_53255766 | 1.14 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr19_-_38916822 | 1.13 |
ENST00000586305.1
|
RASGRP4
|
RAS guanyl releasing protein 4 |
chr1_+_78470530 | 1.13 |
ENST00000370763.5
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4 |
chr12_+_79258547 | 1.12 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr6_-_32157947 | 1.11 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr19_+_34745442 | 1.10 |
ENST00000299505.6
ENST00000588470.1 ENST00000589583.1 ENST00000588338.2 |
KIAA0355
|
KIAA0355 |
chr9_+_71320557 | 1.08 |
ENST00000541509.1
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
chr17_+_7758374 | 1.06 |
ENST00000301599.6
ENST00000574668.1 |
TMEM88
|
transmembrane protein 88 |
chr3_-_171177852 | 1.06 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
chr17_-_49337392 | 1.06 |
ENST00000376381.2
ENST00000586178.1 |
MBTD1
|
mbt domain containing 1 |
chrX_-_70473957 | 1.04 |
ENST00000373984.3
ENST00000314425.5 ENST00000373982.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr2_+_45878790 | 1.04 |
ENST00000306156.3
|
PRKCE
|
protein kinase C, epsilon |
chr8_-_4852494 | 1.02 |
ENST00000520002.1
ENST00000602557.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr10_+_35416223 | 1.01 |
ENST00000489321.1
ENST00000427847.2 ENST00000345491.3 ENST00000395895.2 ENST00000374728.3 ENST00000487132.1 |
CREM
|
cAMP responsive element modulator |
chr8_+_95907993 | 0.99 |
ENST00000523378.1
|
NDUFAF6
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
chrX_-_128657457 | 0.98 |
ENST00000371121.3
ENST00000371123.1 ENST00000371122.4 |
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr17_-_39968855 | 0.98 |
ENST00000355468.3
ENST00000590496.1 |
LEPREL4
|
leprecan-like 4 |
chr10_-_126849588 | 0.97 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
chr3_+_9975497 | 0.96 |
ENST00000397170.3
ENST00000383811.3 ENST00000452070.1 ENST00000326434.5 |
CRELD1
|
cysteine-rich with EGF-like domains 1 |
chr3_-_169381183 | 0.96 |
ENST00000494292.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr20_+_34680620 | 0.95 |
ENST00000430276.1
ENST00000373950.2 ENST00000452261.1 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr2_+_61108650 | 0.93 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr19_-_11347173 | 0.93 |
ENST00000587656.1
|
DOCK6
|
dedicator of cytokinesis 6 |
chr1_+_150337144 | 0.92 |
ENST00000539519.1
ENST00000369067.3 ENST00000369068.4 |
RPRD2
|
regulation of nuclear pre-mRNA domain containing 2 |
chr17_-_58469591 | 0.92 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr2_+_61108771 | 0.91 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr3_-_168864427 | 0.91 |
ENST00000468789.1
|
MECOM
|
MDS1 and EVI1 complex locus |
chr8_-_4852218 | 0.90 |
ENST00000400186.3
ENST00000602723.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr6_+_37321748 | 0.90 |
ENST00000373479.4
ENST00000394443.4 |
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase |
chr9_+_130830451 | 0.88 |
ENST00000373068.2
ENST00000373069.5 |
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr3_+_194406603 | 0.88 |
ENST00000329759.4
|
FAM43A
|
family with sequence similarity 43, member A |
chr1_-_53018654 | 0.88 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
chr11_+_47279504 | 0.88 |
ENST00000441012.2
ENST00000437276.1 ENST00000436029.1 ENST00000467728.1 ENST00000405853.3 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
chr19_+_34287751 | 0.87 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr12_+_57482877 | 0.87 |
ENST00000342556.6
ENST00000357680.4 |
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr2_+_159313452 | 0.87 |
ENST00000389757.3
ENST00000389759.3 |
PKP4
|
plakophilin 4 |
chr2_+_219264466 | 0.87 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr15_-_82338460 | 0.87 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
chr1_+_37940153 | 0.86 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr3_-_93692781 | 0.85 |
ENST00000394236.3
|
PROS1
|
protein S (alpha) |
chr2_+_217498105 | 0.85 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
chr6_+_34857019 | 0.85 |
ENST00000360359.3
ENST00000535627.1 |
ANKS1A
|
ankyrin repeat and sterile alpha motif domain containing 1A |
chr1_+_43766642 | 0.82 |
ENST00000372476.3
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr19_+_10713112 | 0.82 |
ENST00000590382.1
ENST00000407327.4 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
chr6_+_32944119 | 0.81 |
ENST00000606059.1
|
BRD2
|
bromodomain containing 2 |
chr17_+_38278530 | 0.81 |
ENST00000398532.4
|
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
chr13_-_110438914 | 0.81 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr6_-_42016385 | 0.80 |
ENST00000502771.1
ENST00000508143.1 ENST00000514588.1 ENST00000510503.1 ENST00000415497.2 ENST00000372988.4 |
CCND3
|
cyclin D3 |
chr1_+_6845578 | 0.79 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr1_+_32538492 | 0.78 |
ENST00000336294.5
|
TMEM39B
|
transmembrane protein 39B |
chr11_+_86748863 | 0.77 |
ENST00000340353.7
|
TMEM135
|
transmembrane protein 135 |
chrX_-_119695279 | 0.76 |
ENST00000336592.6
|
CUL4B
|
cullin 4B |
chrX_-_70474377 | 0.76 |
ENST00000373978.1
ENST00000373981.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr6_+_148663729 | 0.76 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
chr19_-_14316980 | 0.75 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
chr1_-_36022979 | 0.75 |
ENST00000469892.1
ENST00000325722.3 |
KIAA0319L
|
KIAA0319-like |
chr11_+_64002292 | 0.75 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
chr14_+_75746340 | 0.75 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr2_+_173686303 | 0.74 |
ENST00000397087.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr16_-_28222797 | 0.74 |
ENST00000569951.1
ENST00000565698.1 |
XPO6
|
exportin 6 |
chr8_-_89339705 | 0.73 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
chr12_+_57482665 | 0.73 |
ENST00000300131.3
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr4_+_88928777 | 0.72 |
ENST00000237596.2
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant) |
chr13_+_36050881 | 0.72 |
ENST00000537702.1
|
NBEA
|
neurobeachin |
chr8_-_103668114 | 0.71 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr1_+_93913665 | 0.70 |
ENST00000271234.7
ENST00000370256.4 ENST00000260506.8 |
FNBP1L
|
formin binding protein 1-like |
chr8_+_29952914 | 0.69 |
ENST00000321250.8
ENST00000518001.1 ENST00000520682.1 ENST00000442880.2 ENST00000523116.1 |
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr19_-_6459746 | 0.69 |
ENST00000301454.4
ENST00000334510.5 |
SLC25A23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr14_-_23822061 | 0.68 |
ENST00000397260.3
|
SLC22A17
|
solute carrier family 22, member 17 |
chr6_-_110500905 | 0.68 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr6_-_42946947 | 0.67 |
ENST00000304611.8
|
PEX6
|
peroxisomal biogenesis factor 6 |
chr6_-_52860171 | 0.67 |
ENST00000370963.4
|
GSTA4
|
glutathione S-transferase alpha 4 |
chr11_-_66445219 | 0.67 |
ENST00000525754.1
ENST00000531969.1 ENST00000524637.1 ENST00000531036.2 ENST00000310046.4 |
RBM4B
|
RNA binding motif protein 4B |
chr14_-_23822080 | 0.67 |
ENST00000397267.1
ENST00000354772.3 |
SLC22A17
|
solute carrier family 22, member 17 |
chr1_+_32538520 | 0.66 |
ENST00000438825.1
ENST00000456834.2 ENST00000373634.4 ENST00000427288.1 |
TMEM39B
|
transmembrane protein 39B |
chr18_+_46065393 | 0.65 |
ENST00000256413.3
|
CTIF
|
CBP80/20-dependent translation initiation factor |
chr11_-_57283159 | 0.64 |
ENST00000533263.1
ENST00000278426.3 |
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
chr18_+_46065483 | 0.64 |
ENST00000382998.4
|
CTIF
|
CBP80/20-dependent translation initiation factor |
chr19_-_41859814 | 0.64 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
chr7_+_114562616 | 0.64 |
ENST00000448022.1
|
MDFIC
|
MyoD family inhibitor domain containing |
chr11_-_124632179 | 0.63 |
ENST00000278927.5
ENST00000442070.2 ENST00000444566.1 ENST00000435477.1 |
ESAM
|
endothelial cell adhesion molecule |
chrX_+_102883887 | 0.63 |
ENST00000372625.3
ENST00000372624.3 |
TCEAL1
|
transcription elongation factor A (SII)-like 1 |
chr17_-_42277203 | 0.63 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr14_+_29241910 | 0.63 |
ENST00000399387.4
ENST00000552957.1 ENST00000548213.1 |
C14orf23
|
chromosome 14 open reading frame 23 |
chr11_-_130184555 | 0.62 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
chr16_+_29827832 | 0.62 |
ENST00000609618.1
|
PAGR1
|
PAXIP1-associated glutamate-rich protein 1 |
chr20_+_306177 | 0.62 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr17_-_62915574 | 0.61 |
ENST00000339474.5
ENST00000581368.1 |
LRRC37A3
|
leucine rich repeat containing 37, member A3 |
chr12_-_48152611 | 0.61 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr17_-_7166500 | 0.61 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
chrX_+_73641286 | 0.60 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr17_+_4618734 | 0.60 |
ENST00000571206.1
|
ARRB2
|
arrestin, beta 2 |
chr3_-_39196049 | 0.59 |
ENST00000514182.1
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1 |
chr8_+_29953163 | 0.58 |
ENST00000518192.1
|
LEPROTL1
|
leptin receptor overlapping transcript-like 1 |
chr19_+_13051206 | 0.58 |
ENST00000586760.1
|
CALR
|
calreticulin |
chr19_-_14201776 | 0.58 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr6_-_32077078 | 0.58 |
ENST00000479795.1
|
TNXB
|
tenascin XB |
chr12_-_48152853 | 0.58 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr17_-_48943706 | 0.56 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
chr1_+_6845497 | 0.56 |
ENST00000473578.1
ENST00000557126.1 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr11_+_63448955 | 0.56 |
ENST00000377819.5
ENST00000339997.4 ENST00000540798.1 ENST00000545432.1 ENST00000543552.1 ENST00000537981.1 |
RTN3
|
reticulon 3 |
chr2_-_216300784 | 0.55 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr2_+_33172012 | 0.54 |
ENST00000404816.2
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
chr4_+_129730947 | 0.54 |
ENST00000452328.2
ENST00000504089.1 |
PHF17
|
jade family PHD finger 1 |
chr17_+_7211656 | 0.54 |
ENST00000416016.2
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr11_+_47291193 | 0.53 |
ENST00000428807.1
ENST00000402799.1 ENST00000406482.1 ENST00000349238.3 ENST00000311027.5 ENST00000407859.3 ENST00000395344.3 ENST00000444117.1 |
MADD
|
MAP-kinase activating death domain |
chr2_-_217236750 | 0.52 |
ENST00000273067.4
|
MARCH4
|
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase |
chr19_-_46272462 | 0.52 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
chr9_-_86432547 | 0.52 |
ENST00000376365.3
ENST00000376371.2 |
GKAP1
|
G kinase anchoring protein 1 |
chr6_+_37321823 | 0.52 |
ENST00000487950.1
ENST00000469731.1 |
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase |
chr16_-_49890016 | 0.51 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr17_-_36956155 | 0.51 |
ENST00000269554.3
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr2_+_203241531 | 0.51 |
ENST00000374580.4
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
chr11_+_64001962 | 0.51 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
chr17_+_4613776 | 0.51 |
ENST00000269260.2
|
ARRB2
|
arrestin, beta 2 |
chr5_-_90679145 | 0.51 |
ENST00000265138.3
|
ARRDC3
|
arrestin domain containing 3 |
chr11_+_63448918 | 0.50 |
ENST00000341307.2
ENST00000356000.3 ENST00000542238.1 |
RTN3
|
reticulon 3 |
chr1_+_97188188 | 0.50 |
ENST00000541987.1
|
PTBP2
|
polypyrimidine tract binding protein 2 |
chr1_+_162602244 | 0.50 |
ENST00000367922.3
ENST00000367921.3 |
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
chr17_+_4613918 | 0.50 |
ENST00000574954.1
ENST00000346341.2 ENST00000572457.1 ENST00000381488.6 ENST00000412477.3 ENST00000571428.1 ENST00000575877.1 |
ARRB2
|
arrestin, beta 2 |
chr9_-_34376851 | 0.49 |
ENST00000297625.7
|
KIAA1161
|
KIAA1161 |
chr11_-_130184470 | 0.49 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
chr1_-_8585945 | 0.49 |
ENST00000377464.1
|
RERE
|
arginine-glutamic acid dipeptide (RE) repeats |
chr1_+_178694300 | 0.49 |
ENST00000367635.3
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
chr4_+_129730779 | 0.49 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr8_-_38126635 | 0.49 |
ENST00000529359.1
|
PPAPDC1B
|
phosphatidic acid phosphatase type 2 domain containing 1B |
chr1_+_211432593 | 0.48 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
chr1_+_150337100 | 0.47 |
ENST00000401000.4
|
RPRD2
|
regulation of nuclear pre-mRNA domain containing 2 |
chr2_+_16080659 | 0.47 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr11_-_67210930 | 0.47 |
ENST00000453768.2
ENST00000545016.1 ENST00000341356.5 |
CORO1B
|
coronin, actin binding protein, 1B |
chr1_+_27022839 | 0.47 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr1_-_154928562 | 0.46 |
ENST00000368463.3
ENST00000539880.1 ENST00000542459.1 ENST00000368460.3 ENST00000368465.1 |
PBXIP1
|
pre-B-cell leukemia homeobox interacting protein 1 |
chr12_-_48152428 | 0.46 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr17_+_2240775 | 0.46 |
ENST00000268989.3
ENST00000426855.2 |
SGSM2
|
small G protein signaling modulator 2 |
chr19_+_39904168 | 0.45 |
ENST00000438123.1
ENST00000409797.2 ENST00000451354.2 |
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
chrX_+_54834791 | 0.45 |
ENST00000218439.4
ENST00000375058.1 ENST00000375060.1 |
MAGED2
|
melanoma antigen family D, 2 |
chr6_+_32936353 | 0.45 |
ENST00000374825.4
|
BRD2
|
bromodomain containing 2 |
chr3_-_114343039 | 0.45 |
ENST00000481632.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr6_+_35227449 | 0.45 |
ENST00000373953.3
ENST00000440666.2 ENST00000339411.5 |
ZNF76
|
zinc finger protein 76 |
chr12_-_49259643 | 0.44 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr19_-_36523709 | 0.44 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr19_-_12721616 | 0.44 |
ENST00000311437.6
|
ZNF490
|
zinc finger protein 490 |
chr14_+_66975213 | 0.44 |
ENST00000543237.1
ENST00000305960.9 |
GPHN
|
gephyrin |
chr9_+_17134980 | 0.44 |
ENST00000380647.3
|
CNTLN
|
centlein, centrosomal protein |
chr3_-_105587879 | 0.44 |
ENST00000264122.4
ENST00000403724.1 ENST00000405772.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr7_+_8008418 | 0.43 |
ENST00000223145.5
|
GLCCI1
|
glucocorticoid induced transcript 1 |
chr12_+_6875519 | 0.43 |
ENST00000389462.4
ENST00000540874.1 ENST00000309083.6 |
PTMS
|
parathymosin |
chrX_+_70521584 | 0.43 |
ENST00000373829.3
ENST00000538820.1 |
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2 |
chr12_-_57824739 | 0.43 |
ENST00000347140.3
ENST00000402412.1 |
R3HDM2
|
R3H domain containing 2 |
chrX_+_134654540 | 0.43 |
ENST00000370752.4
|
DDX26B
|
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
chr12_+_56915776 | 0.43 |
ENST00000550726.1
ENST00000542360.1 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr1_-_221915418 | 0.43 |
ENST00000323825.3
ENST00000366899.3 |
DUSP10
|
dual specificity phosphatase 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 12.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 2.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.6 | 3.5 | GO:1990822 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
0.5 | 0.5 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.5 | 1.4 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 3.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 1.6 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.4 | 5.1 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 1.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 3.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 1.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.3 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 0.9 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 1.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.3 | 1.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.5 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 0.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 5.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.6 | GO:0052552 | negative regulation of extracellular matrix disassembly(GO:0010716) induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 1.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 1.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 1.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 1.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.2 | 1.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 0.5 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.2 | 1.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.2 | 0.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.2 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.6 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 0.6 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 2.0 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 1.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 1.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.7 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.8 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 1.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 2.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 1.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.6 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 4.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 1.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.3 | GO:0043049 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.6 | GO:1901164 | peptide antigen assembly with MHC protein complex(GO:0002501) negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.2 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 1.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.2 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.5 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 4.7 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.3 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.1 | 2.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 1.2 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.3 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.1 | GO:0060585 | nitric oxide transport(GO:0030185) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 1.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) dipeptide transport(GO:0042938) |
0.0 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.0 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.1 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0060661 | male genitalia morphogenesis(GO:0048808) submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 2.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 1.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.1 | GO:0061428 | peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 1.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 1.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.4 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.7 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.2 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.0 | GO:0070101 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.0 | 0.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.0 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.6 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.8 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.9 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 2.3 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 0.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 3.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 2.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 1.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 2.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 3.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 1.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 10.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 1.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 3.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.5 | 1.6 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.4 | 2.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.4 | 1.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.2 | 3.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 1.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 0.7 | GO:0048763 | HLH domain binding(GO:0043398) calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.2 | 0.9 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 3.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.1 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 1.6 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 2.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 1.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 2.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 6.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 2.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 2.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.0 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) BH3 domain binding(GO:0051434) |
0.0 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 2.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 3.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 3.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 3.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |